International Journal of Drug Policy
Volume 20, Issue 6 , Pages 502-508, November 2009

The legacy of ‘normalisation’: The role of classical and contemporary criminological theory in understanding young people's drug use

  • Fiona Measham

      Affiliations

    • Department of Applied Social Science, Lancaster University, Bowland North, Lancaster LA1 4YT, United Kingdom
  • ,
  • Michael Shiner

      Affiliations

    • Department of Social Policy, London School of Economics, Houghton Street, London WC2A 2AE, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 207 9557415.

Received 9 July 2008; received in revised form 5 January 2009; accepted 5 February 2009. published online 23 March 2009.

Abstract 

Since it began in the mid-1990s, the debate surrounding the normalisation of adolescent recreational drug use has attracted considerable attention and has tended to polarise opinion within the field. In this article two of the main protagonists in the debate come together to discuss its legacy. Focusing on the twin themes of continuity and change the authors begin by considering the relevance of early developments in the sociology of drug use, noting that this earlier work anticipated much that has recently been written on the subject, including the emphasis on hedonism and consumption in leisure lifestyles. From here they go on to critically reflect on the role that structure and agency have played in the normalisation debate, suggesting that the original thesis underplayed the role of structural influences in favour of a rational action model of adolescent drug use. In their more recent work, both authors have come to emphasise how drug use is shaped by an interplay between social structure and human agency. While some areas of disagreement remain, they agree that normalisation is best understood as a contingent process negotiated by distinct social groups operating in bounded situations.

Keywords: Normalisation, Situated choice, Structured action, Structure and agency

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(09)00044-9

doi:10.1016/j.drugpo.2009.02.001

International Journal of Drug Policy
Volume 20, Issue 6 , Pages 502-508, November 2009